C12Y 101/01105
Retinol dehydrogenase
Official title: Retinol dehydrogenase (1.1.1.105)
C12Y101/01105 (Retinol dehydrogenase) appears on 20 US grants and 43 published applications in this corpus.
Search patents in C12Y- Granted patents
- 20
- Published applications
- 43
- Assignees
- 22
- Inventors
- 59
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 2 | 2 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 1 | 2 |
| 2007 | 1 | 2 |
| 2008 | 0 | 6 |
| 2009 | 1 | 2 |
| 2010 | 2 | 0 |
| 2011 | 2 | 1 |
| 2012 | 2 | 1 |
| 2013 | 1 | 1 |
| 2014 | 0 | 2 |
| 2015 | 2 | 2 |
| 2016 | 1 | 1 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 2 |
| 2021 | 0 | 1 |
| 2022 | 0 | 3 |
| 2023 | 1 | 2 |
| 2024 | 1 | 3 |
| 2025 | 2 | 3 |
| 2026 | 1 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Viral vectors comprising RDH12 coding regions and methods of treating retinal dystrophies31 Mar 2026US 12,589,136 B2The Regents of the University of Michigan
- Transgene cassettes designed to express a human MECP2 gene15 Jul 2025US 12,359,219 B2Board of Regents, The University of Texas System
- Biosynthesis of retinoids18 Mar 2025US 12,252,724 B2Dsm IP Assets B.V.
- Transgene cassettes designed to express a human MECP2 gene6 Feb 2024US 11,891,616 B2Board of Regents, The University of Texas System
- Biosynthesis of retinoids14 Feb 2023US 11,578,344 B2Dsm IP Assets B.V.
- Fusion proteins for improved gene editing24 Sep 2026US 2026/0286397 A1New York Genome Center, Inc.
- Host cells capable of producing retinol or retinol precursors and methods of use thereof6 Aug 2026US 2026/0226526 A1Amyris, Inc.
- Viral vectors comprising rdh12 coding regions and methods of treating retinal dystrophies11 Jun 2026US 2026/0158118 A1The Regents of the University of Michigan
- 17beta-hydroxysteroid dehydrogenase type 13 (hsd17b13) irna compositions and methods of use thereof2 Oct 2025US 2025/0304967 A1Alnylam Pharmaceuticals, Inc.
- Transgene cassettes designed to express a human mecp2 gene25 Sep 2025US 2025/0297285 A1Board of Regents, The University of Texas System
Most cited
By later US patents
- Albumin fusion proteins comprising GLP-1 polypeptides198US 7,141,547 B2Human Genome Sciences, Inc. · 2006
- Albumin fusion proteins96US 7,592,010 B2Delta Biotechnology Limited · 2009
- Albumin fusion proteins34US 7,847,079 B2Human Genome Sciences, Inc. · 2010
- Albumin fusion proteins34US 8,252,739 B2Human Genome Sciences, Inc. · 2012
- G-CSF-albumin fusion proteins28US 8,012,464 B2Human Genome Sciences, Inc. · 2011